These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18825466)

  • 1. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?
    Ramos-De la Medina A; Remes-Troche JM; Roesch-Dietlen FB; Pérez-Morales AG; Martinez S; Cid-Juarez S
    J Gastrointest Surg; 2008 Dec; 12(12):2097-102; discussion 2102. PubMed ID: 18825466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
    Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease].
    Roesch-Dietlen F; Pérez-Morales A; Melo-Santisteban G; Díaz-Blanco F; Martínez-Fernández S; Martínez JA; Cid-Juárez S
    Cir Cir; 2008; 76(1):37-42. PubMed ID: 18492418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of non-alcoholic fatty liver disease and hypercholesterolemia in patients with gallstone disease undergoing laparoscopic cholecystectomy.
    Singh K; Dahiya D; Kaman L; Das A
    Pol Przegl Chir; 2019 Nov; 92(1):18-22. PubMed ID: 32312927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of nonalcoholic fatty liver disease in patients undergoing laparoscopic cholecystectomy.
    Hajong R; Dhal MR; Naku N; Kapa B
    J Family Med Prim Care; 2018; 7(6):1375-1378. PubMed ID: 30613527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.
    Yilmaz Y; Ayyildiz T; Akin H; Colak Y; Ozturk O; Senates E; Tuncer I; Dolar E
    Gut Liver; 2014 May; 8(3):313-7. PubMed ID: 24827629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.
    Fracanzani AL; Valenti L; Russello M; Miele L; Bertelli C; Bellia A; Masetti C; Cefalo C; Grieco A; Marchesini G; Fargion S
    PLoS One; 2012; 7(7):e41183. PubMed ID: 22848440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
    Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
    J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.
    Reddy SK; Zhan M; Alexander HR; El-Kamary SS
    World J Gastroenterol; 2013 Dec; 19(45):8301-11. PubMed ID: 24363521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
    Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
    Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease.
    Alsaif FA; Alqahtani SH; Alsadoon AM; Alswat KA; Abdo AA; Hassanain MM; Alsharabi AB; Aljuhani GR; Alkhalidi HM; Elsharkawy MS; Alotaibi MA; Sanai FM; Al-Hamoudi WK
    Saudi J Gastroenterol; 2020 Apr; 26(4):204-9. PubMed ID: 32341228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.
    Udelsman BV; Corey KE; Lindvall C; Gee DW; Meireles OR; Hutter MM; Chang DC; Witkowski ER
    Surg Obes Relat Dis; 2019 Jun; 15(6):843-849. PubMed ID: 31014948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
    Treeprasertsuk S; Björnsson E; Enders F; Suwanwalaikorn S; Lindor KD
    World J Gastroenterol; 2013 Feb; 19(8):1219-29. PubMed ID: 23482703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
    Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
    Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.
    Pérez-Gutiérrez OZ; Hernández-Rocha C; Candia-Balboa RA; Arrese MA; Benítez C; Brizuela-Alcántara DC; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2013; 12(3):416-24. PubMed ID: 23619258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
    Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease].
    Cherkashchenko NA; Livzan MA; Krolevets TS
    Ter Arkh; 2020 Sep; 92(8):29-36. PubMed ID: 33346459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.